At end-point there was no difference between treatment groups with respect to the proportion of CD11b positive infiltrating neutrophils (Fig. S5B and C), the tumor number per mouse (Fig. S5D) or tumor area in the lungs (Fig. S5E). Here, ITGAM is linked to neoplasm.